Sigma Planning Corp’s Medicenna Therapeutics Corp. Common Shares MDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-634,550
| Closed | -$187K | – | 1215 |
|
|
2023
Q3 | $187K | Buy |
634,550
+329,250
| +108% | +$97.1K | 0.01% | 1102 |
|
|
2023
Q2 | $147K | Buy |
305,300
+3,250
| +1% | +$1.57K | 0.01% | 1129 |
|
|
2023
Q1 | $190K | Sell |
302,050
-500
| -0.2% | -$315 | 0.01% | 1183 |
|
|
2022
Q4 | $139K | Buy |
302,550
+39,500
| +15% | +$18.1K | 0.01% | 1170 |
|
|
2022
Q3 | $218K | Buy |
263,050
+11,000
| +4% | +$9.12K | 0.01% | 1079 |
|
|
2022
Q2 | $292K | Buy |
252,050
+51,750
| +26% | +$60K | 0.01% | 999 |
|
|
2022
Q1 | $256K | Buy |
200,300
+60,250
| +43% | +$77K | 0.01% | 1128 |
|
|
2021
Q4 | $228K | Buy |
140,050
+109,550
| +359% | +$178K | 0.01% | 1203 |
|
|
2021
Q3 | $84K | Buy |
+30,500
| New | +$84K | ﹤0.01% | 1309 |
|